Related Experiment Video
Updated: Aug 5, 2026

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel Film
Published on: December 13, 2024
Solubility-Enhanced α‑Mangostin Bilayer Films: Synergizing Mucoadhesion and Protection for Effective Aphthous Ulcer
Waree Tiyaboonchai1, Jiratchaya Lerdsrimongkol1, Prajaree Kuenkoungdee1
1Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Abstract:
Aphthous ulcers are prevalent and painful oral mucosal lesions that substantially compromise patient quality of life, requiring effective localized treatment. α-Mangostin, a bioactive compound from mangosteen pericarp, exhibits potent anti-inflammatory properties but suffers from poor aqueous solubility. This study developed a double-layer mucoadhesive film incorporating an α-mangostin-based solid dispersion (MPESD) to enhance solubility and provide dual-functionality: protection and therapy. Mangosteen peel extract was formulated into solid dispersions using PVP K30, significantly enhancing solubility from undetectable levels to 8.12 ± 0.04 mg/mL (1:4 ratio). The films, comprising an ethylcellulose backing layer and a gelatin-HPMC mucoadhesive layer, were fabricated via solvent casting. Mechanical testing confirmed suitable puncture strength (1.63 N/mm2) and flexibility (20% elongation) for oral application. The inclusion of HPMC improved surface wettability and prolonged in vitro residence time to >8 h, while the optimized film achieved 96% drug release within 2 h. These findings demonstrate that the MPESD-loaded double-layer film presents a promising formulation strategy with the potential for managing aphthous ulcers.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Solubility Enhancement
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
